Mapping the effectiveness and risks of GLP-1 receptor agonists

Jan. 20, 2025, 4:46 p.m.

An atlas of the associations between the use of GLP-1 receptor agonists (GLP-1RAs) and 175 health outcomes reports the effectiveness and risks of GLP-1RAs compared with other antihyperglycemic medications, such as sulfonylureas, DPP4 inhibitors and SGLT2 inhibitors.

Welcome to Newscon
View the latest news and breaking news today for business, technology, entertainment, health... at Newscon.net
              Watch
Make Newscon yours
Follow all the topics you care about, and we’ll deliver the best stories for you.
              Explore
Become a member
Become a member to response to your stories
              Login

NEWSCON

Mapping the effectiveness and risks of GLP-1 receptor agonists